-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, as counterfeit drugs against AIDS (HIV) drugs such as Biktarvy, Descovy and Symtuza are rampant, the US Department of Justice has launched an investigation into counterfeit drugs from Gilead, GlaxoSmithKline and Johnson & Johnson, and strives to clear the circulation system of patients' health and treatment.
Substandard drugs
.
Biktarvy and Descovy are both anti-AIDS drugs under Gilead
.
Among them, Biktarvy is an antiretroviral cocktail therapy for HIV/AIDS, consisting of three fixed-dose drugs, and in 2020, the sales of the drug reached 8.
In July 2021, Gilead sued a drug distributor with 70 pharmacies, alleging they sold more than $250 million in counterfeit Biktarvy and Descovy drugs in the U.
S.
over the past two years, seriously endangering the health of patients
.
The company issued a statement in August 2021 alerting consumers to the substandard and falsified Biktarvy and Descovy drugs that are on the rise in the United States
It's not just Gilead that is troubled by counterfeit anti-AIDS drugs.
Johnson & Johnson warned patients of counterfeit drugs for its anti-HIV drug Symtuza as early as the end of 2020
.
During the pandemic, the sale of counterfeit medicines has increased due to disruptions in legitimate supply chains and limited regulatory enforcement
Anti-HIV drugs are often provided by Medicare and Medicaid to patients in need at low or no cost, by manufacturers buying the drugs from homeless or drug-addicted AIDS patients and falsely resold to pharmacies
.
Patients taking Biktarvy will cost $3,751 per month, while Johnson & Johnson's Symtuza costs even more at $4,490 per month
In some cases, the resold drugs were from the original manufacturer but expired or were falsely resold
.
In other cases, the drugs were over-the-counter pain relievers or antipsychotics rather than antivirals, and they were simply put in vials labeled Biktarvy or Descovy
At present, the U.
S.
Department of Justice has intervened in the investigation and worked with related companies and the FDA to remove all counterfeit drugs
.
Maryland-based wholesale distributor Safe Chain Solutions is one of the defendants in Gilead's lawsuit, but the company says it never knowingly sold counterfeit products
Original source:
https://
https:// https://
